M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe-Reference-Cited by-同舟云学术

M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe

Published:2011-12 Issue:11 Volume:82 Page:1604-1618
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Evison Benny J.,Pastuovic Mile,Bilardi Rebecca A.,Forrest Robert A.,Pumuye Paul P.,Sleebs Brad E.,Watson Keith G.,Phillips Don R.,Cutts Suzanne M.

Funder

National Health

Medical Research Council

Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference57 articles.

1. Cancer facts: a concise oncology text;Bishop,1999

2. Cancer: principles & practice of oncology;DeVita,2001

3. Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer;Faulds;Drugs,1991

4. Pixantrone for the treatment of aggressive non-Hodgkin lymphoma;Mukherji;Expert Opin Pharmacother,2010

5. Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones;Hazlehurst;Cancer Lett,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma;Hepatology;2023-10-11

2. An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells;Cancer Chemotherapy and Pharmacology;2022-04-23

3. Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features;Bioorganic & Medicinal Chemistry;2020-02

4. Mitotic Catastrophe;Apoptosis and Beyond;2018-10-05

5. Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer;ACS Medicinal Chemistry Letters;2017-04-28